Alkermes (ALKS) Other Accumulated Expenses (2011 - 2026)

Alkermes' (ALKS) quarterly Other Accumulated Expenses came in at $136.8 million in Q1 2026, up 64.63% year-on-year from $83.1 million in Q1 2025, and up 37.94% on a QoQ basis from $99.2 million in Q4 2025.

Alkermes (ALKS) Other Accumulated Expenses (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has 16 years of Other Accumulated Expenses data on file, last reported at $136.8 million in Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 64.63% year-over-year to $136.8 million in Q1 2026; TTM through Mar 2026 was $136.8 million, a 64.63% increase from a year earlier, with the FY2025 full-year figure at $99.2 million, up 44.26% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $136.8 million, up from $99.2 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for ALKS reached as high as $136.8 million in Q1 2026 and fell as low as $67.3 million in Q3 2024.
  • Historically, Other Accumulated Expenses has averaged $93.3 million across 5 years, with a median of $91.0 million in 2022.
  • Across the five-year window, Other Accumulated Expenses decreased 25.12% in 2024 and jumped 64.63% in 2026, its largest moves.
  • Year by year, Other Accumulated Expenses stood at $108.2 million in 2022, then decreased by 15.12% to $91.8 million in 2023, then dropped by 25.12% to $68.7 million in 2024, then surged by 44.26% to $99.2 million in 2025, then jumped by 37.94% to $136.8 million in 2026.
  • Per Business Quant data, the three most recent Other Accumulated Expenses figures were $136.8 million in Q1 2026, $99.2 million in Q4 2025, and $79.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 136.79 Mn
Dec 31, 2025 99.17 Mn
Sep 30, 2025 79.79 Mn
Jun 30, 2025 90.00 Mn
Mar 31, 2025 83.09 Mn
Dec 31, 2024 68.74 Mn
Sep 30, 2024 67.26 Mn
Jun 30, 2024 85.64 Mn
Mar 31, 2024 81.59 Mn
Dec 31, 2023 91.81 Mn
Sep 30, 2023 88.45 Mn
Jun 30, 2023 98.35 Mn
Mar 31, 2023 105.30 Mn
Dec 31, 2022 108.16 Mn
Sep 30, 2022 117.06 Mn
Jun 30, 2022 93.90 Mn
Mar 31, 2022 91.02 Mn
Dec 31, 2021 75.51 Mn
Sep 30, 2021 101.44 Mn
Jun 30, 2021 68.05 Mn